The isopeptidase inhibitor 2cPE triggers proteotoxic stress and ATM activation in chronic lymphocytic leukemia cells
Metrics: PDF 1459 views | HTML 1753 views | ?
Andrea Tomasella1, Raffaella Picco1, Sonia Ciotti1, Andrea Sgorbissa1, Elisa Bianchi2, Rossella Manfredini2, Fabio Benedetti3, Valentina Trimarco4, Federica Frezzato4, Livio Trentin4, Gianpietro Semenzato4, Domenico Delia5, Claudio Brancolini1,2
1Department of Medical and Biological Sciences, Università degli Studi di Udine, Udine, Italy
2Centre for Regenerative Medicine “Stefano Ferrari”, Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy
3Dipartimento di Scienze Chimiche e Farmaceutiche, Università degli Studi di Trieste, Trieste, Italy
4Department of Medicine, Hematology and Clinical Immunology Branch, Padua University School of Medicine, Padua, Italy
5Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Claudio Brancolini, email: firstname.lastname@example.org
Keywords: CLL, apoptosis, proteasome, proteotoxic stress, deubuquitylases
Received: November 15, 2015 Accepted: May 22, 2016 Published: May 31, 2016
Relapse after treatment is a common and unresolved problem for patients suffering of the B-cell chronic lymphocytic leukemia (B-CLL). Here we investigated the ability of the isopeptidase inhibitor 2cPE to trigger apoptosis in leukemia cells in comparison with bortezomib, another inhibitor of the ubiquitin-proteasome system (UPS). Both inhibitors trigger apoptosis in CLL B cells and gene expression profiles studies denoted how a substantial part of genes up-regulated by these compounds are elements of adaptive responses, aimed to sustain cell survival. 2cPE treatment elicits the up-regulation of chaperones, proteasomal subunits and elements of the anti-oxidant response. Selective inhibition of these responses augments apoptosis in response to 2cPE treatment. We have also observed that the product of the ataxia telangiectasia mutated gene (ATM) is activated in 2cPE treated cells. Stimulation of ATM signaling is possibly dependent on the alteration of the redox homeostasis. Importantly ATM inhibition, mutations or down-modulation increase cell death in response to 2cPE. Overall this work suggests that 2cPE could offer new opportunities for the treatment of B-CLL.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.